Alon Musk’s machine-to-human interface company, Neuralink announced via Twitter they received the FDA’s approval to begin first-in-human clinical trials. For those of you brave enough who wish to participate in the future trial, you can register on Neuralink’s Patient Register.
Anthrobots: Tiny Biological Healers from Human Cells Show Remarkable Regenerative Abilities
Researchers at Tufts University have recently unveiled a groundbreaking development in the field of biobots—tiny biological robots called Anthrobots.